Skip to main content

Table 1 Baseline characteristics of all the children in the study

From: Tocotrienol-rich fractions (TRF) supplementation in school-going children with Attention Deficit/Hyperactive Disorder (ADHD): a randomized controlled trial

 

Placebo n = 73

TRF n = 73

p value

Age in years (mean, SD)

9.4 (1.7)

9.4 (1.9)

0.854

Male: Female ratio

61 male: 12 female

63 male: 10 female

0.644

Education Type (n)

   

 Mainstream

58

56

0.689

 Special education

13

15

 

 Others

2

2

 

Parental Education (n)

   

 None/Primary

7

9

0.866

 Secondary

46

45

 

 Tertiary

20

19

 

ADHD subtypes (n)

   

 Inattentive

9

8

0.796

 Combined

64

65

 

Presence of comorbid conditions (n)

30

26

0.496

Medication for ADHD (n)

35

43

0.184

Mean Baseline VAPRS total symptom score (SD)

28.97 (9.37)

28.91 (10.37)

0.976

Mean Baseline VATRS total symptom score (SD)a

25.83 (10.35)a

25.40 (10.55)a

0.844

Baseline tocotrienol levels (Median)

   

 Delta (ng/ml)

9.900

10.050

0.967

 Gamma (ng/ml)

43.30

48.40

0.709

 Alpha (ng/ml)

24.60

26.40

0.935

  1. aOnly 95 VATRS were returned (53 from placebo group, 42 from TRF group)